Clinical Trials Browser

Phase 1/2 × Lymphoma, B-Cell × blinatumomab × Clear all

NCT03114865 2025-05-22

A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Phase 1/2 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma